Evaluation of the effects of dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non‐alcoholic fatty liver disease

达帕格列嗪 瞬态弹性成像 脂肪变性 内科学 脂肪肝 胃肠病学 医学 2型糖尿病 纤维化 安慰剂 糖尿病 内分泌学 肝纤维化 病理 疾病 替代医学
作者
Masanori Shimizu,Kunihiro Suzuki,Kanako Kato,Teruo Jojima,Toshie Iijima,Toshimitsu Murohisa,Makoto Iijima,Hidehiro Takekawa,Isao Usui,Hideyuki Hiraishi,Yoshimasa Aso
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:21 (2): 285-292 被引量:305
标识
DOI:10.1111/dom.13520
摘要

Aims To investigate the effects of dapagliflozin on liver steatosis and fibrosis evaluated in patients with type 2 diabetes and non‐alcoholic fatty liver disease (NAFLD). Materials and methods In a randomized, active‐controlled, open‐label trial, 57 patients with type 2 diabetes and NAFLD were randomized to a dapagliflozin group (5 mg/d; n = 33) or a control group (n = 24) and were treated for 24 weeks. Hepatic steatosis and fibrosis were assessed using transient elastography to measure controlled attenuation parameter (CAP) and liver stiffness, respectively. Results Baseline liver stiffness measurement (LSM) was positively correlated with several markers and scoring systems for liver fibrosis. In week 24, there was a significant decrease in CAP from 314 ± 61 to 290 ± 73 dB/m ( P = 0.0424) in the dapagliflozin group, while there was no significant change in the control group. In addition, LSM tended to decrease from 9.49 ± 6.05 to 8.01 ± 5.78 kPa in the dapagliflozin group. In 14 patients from this group with LSM values ≥8.0 kPa, indicating significant liver fibrosis, LSM decreased significantly from 14.7 ± 5.7 to 11.0 ± 7.3 kPa ( P = 0.0158). Furthermore, serum alanine aminotransferase and γ‐glutamyltranspeptidase levels decreased in the dapagliflozin group, but not in the control group, and visceral fat mass was significantly reduced in the dapagliflozin group. Conclusions Based on these findings, the sodium‐glucose co‐transporter‐2 inhibitor dapagliflozin improves liver steatosis in patients with type 2 diabetes and NAFLD, and attenuates liver fibrosis only in patients with significant liver fibrosis, although the possibility cannot be excluded that a reduction in body weight or visceral adipose tissue by dapagliflozin may be associated with a decrease of liver steatosis or fibrosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一一一给轻松白桃的求助进行了留言
2秒前
zz2905完成签到,获得积分10
2秒前
小超人完成签到 ,获得积分10
3秒前
香蕉初瑶完成签到,获得积分10
3秒前
meimei完成签到 ,获得积分10
3秒前
儒雅的菠萝吹雪完成签到,获得积分10
4秒前
4秒前
5秒前
水寒完成签到,获得积分10
5秒前
拉长的念珍完成签到,获得积分10
6秒前
大气夜山完成签到 ,获得积分10
6秒前
Tristan完成签到 ,获得积分10
8秒前
我思故我在完成签到,获得积分10
8秒前
9秒前
何浏亮完成签到,获得积分10
10秒前
阿成完成签到,获得积分10
10秒前
Pauline完成签到 ,获得积分10
10秒前
11秒前
微笑的语芙完成签到,获得积分10
11秒前
11秒前
小背包完成签到 ,获得积分10
11秒前
水寒发布了新的文献求助10
13秒前
希望天下0贩的0应助17采纳,获得10
13秒前
yu完成签到 ,获得积分10
13秒前
钟瑞乾完成签到,获得积分10
13秒前
花痴的电灯泡完成签到,获得积分10
14秒前
虚心念桃完成签到,获得积分10
15秒前
jiaolulu发布了新的文献求助10
16秒前
zyw完成签到 ,获得积分10
16秒前
ironsilica完成签到,获得积分10
19秒前
20秒前
被动科研完成签到,获得积分10
22秒前
斗牛的番茄完成签到 ,获得积分10
23秒前
所所应助时尚俊驰采纳,获得10
23秒前
zgt01发布了新的文献求助10
27秒前
背后如彤完成签到 ,获得积分10
29秒前
30秒前
通通通完成签到,获得积分10
31秒前
李治海完成签到,获得积分10
31秒前
诸葛烤鸭完成签到,获得积分10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022